Similar articles

• Animal behavior case of the month. Motivation for the tail-chasing behavior was considered to most likely be multifactorial.

  Bain MJ, Fan CM. Bain MJ, et al. J Am Vet Med Assoc. 2012 Mar 15;240(6):673-5. doi: 10.2460/javma.240.6.673. J Am Vet Med Assoc. 2012. PMID: 22380802 No abstract available.
• Gabapentin augmentation for fluoxetine-treated patients with obsessive-compulsive disorder.

  Corá-Locatelli G, Greenberg BD, Martin J, Murphy DL. Corá-Locatelli G, et al. J Clin Psychiatry. 1998 Sep;59(9):480-1. doi: 10.4088/jcp.v59n0907d. J Clin Psychiatry. 1998. PMID: 9771822 Clinical Trial. No abstract available.
• Does gabapentin lead to early symptom improvement in obsessive-compulsive disorder?

  Onder E, Tural U, Gökbakan M. Onder E, et al. Eur Arch Psychiatry Clin Neurosci. 2008 Sep;258(6):319-23. doi: 10.1007/s00406-007-0798-z. Epub 2008 Feb 23. Eur Arch Psychiatry Clin Neurosci. 2008. PMID: 18297416 Clinical Trial.
• [Symptomatic treatment of painful diabetic neuropathy].

  Maeda K, Yasuda H. Maeda K, et al. Nihon Rinsho. 2005 Jun;63 Suppl 6:609-13. Nihon Rinsho. 2005. PMID: 15999779 Review. Japanese. No abstract available.
• Pharmacological treatment of fibromyalgia and other chronic musculoskeletal pain.

  Goldenberg DL. Goldenberg DL. Best Pract Res Clin Rheumatol. 2007 Jun;21(3):499-511. doi: 10.1016/j.berh.2007.02.012. Best Pract Res Clin Rheumatol. 2007. PMID: 17602996 Review.